Zydus Cadila receives final USFDA’s nod for Atenolol and Chlorthalidone Tablets
Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Atenolol and Chlorthalidone Tablets USP (US RLD-Tenoretic), 50 mg/25 mg and 100 mg/25 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. This medication is used to treat high blood pressure (hypertension). Lowering … Read more
